Erasca, Inc. (ERAS)
NASDAQ·Healthcare·Biotechnology
$14.20
-1.60%
Mkt Cap $5.04B
Analyst Ratings
Buy
2
Hold
4
Sell
0
Price Target (22 analysts)
$22.50
Range $16.00 – $30.00
Implied Upside
+58.5%
Consensus $22.50 vs current $14.20
NASDAQ·Healthcare·Biotechnology
$14.20
-1.60%
Mkt Cap $5.04B
Buy
2
Hold
4
Sell
0
Price Target (22 analysts)
$22.50
Range $16.00 – $30.00
+58.5%
Consensus $22.50 vs current $14.20